sglt2 and glp 1 combination Insights into the Roles of GLP-1, DPP-4, at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology GLP-1 & SGLT2 Inhibitor Combination

Temporary use of montelukast, ketotifen, and low-dose naltrexone (LDN) stabilized mast cells and reduced pain

Far from being a bystander, mediation analysis indicated that TMAO significantly accelerated the rate of kidney function decline by age, with its effect increasing in more severe disease stages

In further support of this ex vivo finding, the GIPR monoagonist LY3537021 reduced body weight by ~4.1% over 8 weeks in patients with T2D (n = 18) (57)

doi: 10.1038/s41598-020-68777-7 59 LanJCadassouOCorbetCRiantOFeronO

Key Takeaways: Allulose may naturally stimulate GLP-1 release , helping regulate appetite and fat metabolism without the need for injectable drugs